VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.63 EUR | +0.13% |
|
+1.04% | -1.78% |
| 16/05 | Scotiabank Adjusts Price Target on Ventas to $51 From $47 | MT |
| 16/05 | Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.83B 4.44B 402B | Sales 2025 * | 5.1B 4.69B 424B | Capitalization | 19.76B 18.18B 1,645B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M -68.09M -6.16B | Net income 2025 * | -14M -12.88M -1.17B | EV / Sales 2024 * | 6.76 x |
| Net Debt 2024 * | 12.87B 11.84B 1,072B | Net Debt 2025 * | 13B 11.97B 1,083B | EV / Sales 2025 * | 6.43 x |
| P/E ratio 2024 * |
-219
x | P/E ratio 2025 * |
3,233
x | Employees | 486 |
| Yield 2024 * |
3.7% | Yield 2025 * |
3.9% | Free-Float | 99.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More press releases
More news
| 1 day | +0.13% | ||
| 1 week | +1.04% | ||
| Current month | +7.49% | ||
| 1 month | +14.20% | ||
| 3 months | +9.31% | ||
| 6 months | +8.88% | ||
| Current year | -1.78% |
1 week
43.93
44.63
1 month
39.6244.63
Current year
38.9345.87
1 year
37.1745.87
3 years
37.0157.04
5 years
15.2268.19
10 years
15.2271.56
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 01/99/01 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 27/14/27 |
| Chief Tech/Sci/R&D Officer | - | 25/19/25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 07/22/07 |
Matthew Lustig
BRD | Director/Board Member | 63 | 12/11/12 |
Marguerite Nader
BRD | Director/Board Member | 55 | 06/20/06 |
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 44.63 | +0.13% |
| 16/24/16 | 44.57 | +1.04% |
| 15/24/15 | 44.11 | +0.41% |
| 14/24/14 | 43.93 | -0.09% |
| 13/24/13 | 43.97 | -0.45% |
Delayed Quote Deutsche Boerse AG, May 17, 2024 at 11:31 am IST
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
01/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
48.91
USD
Average target price
53.26
USD
Spread / Average Target
+8.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.32% | 60.56B | |
| +0.45% | 14B | |
| -0.10% | 7.57B | |
| -6.79% | 6.01B | |
| +12.06% | 3.56B | |
| +0.46% | 3.32B | |
| -4.32% | 3.15B | |
| +2.04% | 3.01B | |
| +19.09% | 2.89B |
- Stock Market
- Equities
- VTR Stock
- VEN Stock
